Who is sponsoring NCT05598294?

NCT05598294 is sponsored by Ankara University.

What drugs are being tested in NCT05598294?

Interventions in NCT05598294: Mobilization recommendations.

What condition does NCT05598294 study?

NCT05598294 studies Ambulation Difficulty, Physical Examination.

Is NCT05598294 still recruiting?

NCT05598294 is currently status unknown. Last updated 25 January 2024.

Last reviewed 2024-01-25 · How we verify

NCT05598294

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can Wearable Technology Products Change Our Patient Management in Laparoscopic Colorectal Cancer Surgery

Status unknown NA Last updated 25 January 2024

What this trial tests

NA trial testing Mobilization recommendations in Ambulation Difficulty in 190 participants. Status unknown.

Timeline

10 October 2022

Primary endpoint
15 November 2024

15 December 2024

Quick facts

Lead sponsor	Ankara University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	190
Start date	10 October 2022
Primary completion	15 November 2024
Estimated completion	15 December 2024
Sites	2 locations across Turkey (Türkiye)

Drugs / interventions tested

Mobilization recommendations

Conditions studied

Ambulation Difficulty — all drugs for Ambulation Difficulty →
Physical Examination — all drugs for Physical Examination →

Sponsor

Ankara University

Who can join

18 and older, any sex, with Ambulation Difficulty or Physical Examination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The clinical progress of the patients whose mobilization the investigators follow up with wearable technology products will be observed in the early postoperative period until discharge. In this way, the investigators primarily aim to examine whether the bowel movements of our more mobilized patients return earlier.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05598294 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 25 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05598294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing